Eyecelerator Presents a Complimentary Live Stream... 

The Retina Combine: Scouting The Next Generation of Ophthalmic Stars

Recorded Oct. 30, 2020 

Moderators Mark Blumenkranz, MD, and Allen Ho, MD, hosted a game-changing, retina-focused innovation program.

Program Agenda

Overview of Eyecelerator 2020

9:00 – 9:05 AM

Pacific Time

David W. Parke II, MD, Steve Speares, Gil Kliman, MD, Mark S. Blumenkranz, MD, Allen Ho, MD

Novel Strategies for Dry AMD and the Next Horizon After Vitamins: Before, During and After the Onset of Geographic Atrophy 

9:05-9:06 AM

Panelists: Wiley Chambers, MD (FDA), Emily Chew, MD (NEI/NIH), Namrata Saroj, OD

Retina Company Showcases and AMD Panels

9:06-9:55 AM

Retina Company Showcase 1.1: AMD

  1. Allegro Ophthalmics – Vicken Karageozian, MD, President & CEO

  2. Mitotech SA – Natalia Perekhvatova, CEO

  3. Vinci Pharmaceuticals – Philip Gioia, Co-Founder & CEO

  4. LumiThera – Clark Tedford, President & CEO


Panel Discussion 1.1 on AMD

Is vision stabilization, restoration or improvement possible?


Moderator: Allen Ho, MD


Panelists: Emily Chew, MD; Philip Gioia (Vinci Pharmaceuticals); Peter Kaiser, MD; Vicken Karageozian, MD (Allegro Ophthalmics); Natalia Perekhvatova (Mitotech); Namrata Saroj, OD; Clark Tedford (LumiThera)


Retina Company Showcase 1.2: AMD

   5. ONL Therapeutics – David Esposito, CEO

   6. Apellis – Cedric Francois, MD, PhD, Co-Founder & CEO

   7. Iveric Bio – Pravin Dugel, MD, Executive Vice President, Chief Strategy & Business Officer


Panel Discussion 1.2 on AMD

Modulating senescence, complement and cell death pathways to save vision.


Moderated by: Allen Ho, MD


Panelists: Michael Abramoff, MD; Wiley Chambers, MD; Pravin Dugel, MD (Iveric Bio); David Esposito (ONL Therapeutics); Cedric Francois, MD, PhD (Apellis); Julia Haller, MD; Peter Kaiser, MD; Philip Rosenfeld, MD, PhD

Introduction to Showcase 2

 9:55-10:00 AM

Mark S. Blumenkranz, MD

Retina Company Showcase 2: Molecules and Platforms

10:00-10:30 AM

  1. AsclepiX Therapeutics – Theresa Heah, MD, MBA, Chief Medical Officer & Executive Vice President Operations

  2. Bayon Therapeutics – Brian Strem, CEO

  3. CavtheRx – Mike Garanzini, CEO

  4. Cell Care Therapeutics – Nicolas Sohl, Co-Founder & CEO

  5. DelSiTech – Frederic Dargelas, PhD, MBA, Director, Head of Business Development & Alliance Management

  6. DTx Pharma – Arthur Suckow, PhD, CEO

Panel Discussion on Opportunities and Challenges for Small Companies

10:30-10:55 AM

Join the conversation about needs finding, prototyping, IP, licensing, platform vs. focused lead, corporate structure and seed funding  

Moderator: Mark S. Blumenkranz, MD

Panelists: Ali Behbahani, MD (NEA), Jay Duker, MD, Jason Ehrlich, MD, PhD (Kodiak Sciences), Doug Kelly, MD (FDA), Nancy Lurker (EyePoint Pharmaceuticals), Aron Shapiro (Ora), Brian Strem, PhD (Bayon Therapeutics), Arthur Sukow, PhD (DTx Pharma), Cameron Taylor (Guggenheim Partners)

Closing Remarks

10:55-11:00 AM

Mark Blumenkranz, MD and Allen Ho, MD